Call us Today! 201-728-8809 | | Contact | About |
   


Barcode Five Rights System

Use Barcode to prevent medication errors

ADERS ® is a barcode point of care, (BPOC), solution

Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.

Get The Latest Patient Safety and Drug Safety Updates from the FDA

FDA Press Releases RSS Feed

Statement on improving adverse event reporting of compounded drugs to protect patients
Mon, 09/09/2019 - 16:11

The FDA is working to improve adverse event reporting of compounded drugs to protect patients

FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth
Mon, 09/09/2019 - 10:26

FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth

FDA approves first treatment for patients with rare type of lung disease
Fri, 09/06/2019 - 15:16

FDA approves Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition.

Federal judge enters consent decree against Tennessee drug, dietary supplement and device distributors, Basic Reset and Biogenyx, for drug, device and dietary supplement violations
Tue, 09/03/2019 - 16:21

A federal court orders Tennessee-based companies to stop receiving, labeling, holding, or distributing dietary supplements, drugs, and devices

FDA requests recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy, reminds patients and health care professionals to stop using due to potential risks
Tue, 09/03/2019 - 14:15

The FDA is requesting a recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy.

FDA sends warning to company for selling unapproved umbilical cord blood and umbilical cord products that may put patients at risk; continues to warn patients of the risk of unapproved stem cell therapy
Tue, 09/03/2019 - 10:09

: FDA sends warning to company for selling unapproved umbilical cord blood and umbilical cord products that may put patients at risk; continues to warn patients of the risk of unapproved stem cell therapy

Statement on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products
Fri, 08/30/2019 - 16:21

FDA and CDC are providing updates about federal and state efforts to investigate respiratory illnesses reported after the use of e-cigarette products.

FDA recommends health care facilities and manufacturers begin transitioning to duodenoscopes with disposable components to reduce risk of patient infection
Thu, 08/29/2019 - 14:06

FDA recommends duodenoscope manufacturers and health care facilities transition to different types of duodenoscopes that may pose less risk to patient safety.

Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA’s response efforts to the Ebola virus outbreak in the Democratic Republic of Congo
Wed, 08/28/2019 - 13:25

FDA committed to helping the people of the Democratic Republic of Congo effectively confront and end the current Ebola virus outbreak

FDA seeks permanent injunction against company selling unapproved hand sanitizers that claim to prevent infections from numerous pathogens
Wed, 08/28/2019 - 13:25

FDA seeks permanent injunction against company selling unapproved hand sanitizers that claim to prevent infections from numerous pathogens

FDA authorizes emergency use of first Ebola fingerstick test with portable reader
Wed, 08/28/2019 - 13:07

FDA authorizes emergency use of first Ebola fingerstick test with portable reader

Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications
Wed, 08/28/2019 - 09:49

The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications.

FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
Tue, 08/27/2019 - 17:49

FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products
Tue, 08/27/2019 - 14:51

FDA is taking new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products

Statement calling on all sectors of the papaya industry to improve practices to better protect consumers
Mon, 08/26/2019 - 18:00

FDA issues letter to all sectors of papaya industry to improve their safety practices

FDA confirms elevated levels of belladonna in certain homeopathic teething products
Fri, 08/23/2019 - 14:01

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.

FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs
Fri, 08/23/2019 - 14:01

Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA’s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and/or conditions but where the products have not been shown to offer clinical benefits. It also covers situations where products labeled as homeopathic contain potentially harmful ingredients or do not meet current good manufacturing practices.

FDA warns company for putting consumers at risk with drug manufacturing data integrity violations
Tue, 08/20/2019 - 11:22

The FDA posted a warning letter for significant current good manufacturing practice violations, including data integrity issues.

Statement on new results demonstrating continued success of the agency’s youth smoking prevention efforts and significant public health cost savings
Tue, 08/20/2019 - 09:22

A new study in the American Journal of Preventive Medicine highlights the continued success and impact the FDA’s “The Real Cost” campaign has had on youth smoking initiation.

FDA approves new antibiotic to treat community-acquired bacterial pneumonia
Mon, 08/19/2019 - 15:05

The FDA approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

Food and Drugs Administration--Recalls/Safety Alerts

Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance
Tue, 09/10/2019 - 13:21

Hospira, Inc., a Pfizer company, is voluntarily recalling BACTERIOSTATIC WATER for Injection, USP, 30 mL, multi-dose vial, lot W20308, to the Hospital/Retail level. Hospira initiated this recall due to lack of confirmation of sterilization for some vials from this lot.

The Metrix Company of Dubuque, Iowa is Recalling Specific Lots of the Empty IV Flexible Containers (Bag) Marketed Under the Metrix Secure EVA Dual Chamber and Baxter ExactaMix Names, Due to the Potential for Leaking of the IV Bag at the Chamber Divider Rod
Tue, 09/10/2019 - 12:06

The Metrix Company of Dubuque, Iowa is recalling specific lots of the empty IV flexible containers (bag) marketed under the Metrix Secure EVA Dual Chamber and Baxter ExactaMix names, due to the potential for leaking of the IV bag at the chamber divider rod, which could result in a serious infection

Hometown Food Company Issues Voluntary Recall of Martha White Gluten Free Sweet Cornbread Muffin Mix Due to Possible Presence of Gluten
Mon, 09/09/2019 - 16:37

Hometown Food Company today initiated a limited, voluntary, consumer-level recall of approximately 374 cases of two specific lot codes of its Martha White Gluten Free Sweet Cornbread Muffin Mix, due to standard quality batch testing that indicated the presence of gluten derived from wheat, rye

House Of Spices (India) Issues Recall of "MDH Sambar Masala" Due To Salmonella Contamination
Mon, 09/09/2019 - 12:21

House of Spices (India) is recalling different lots of “MDH SAMBAR MASALA”, 3.5oz (100g) UPC code 6291103750327. This product is produced by R-PURE AGRO SPECIALITIES and distributed by HOUSE OF SPICES (INDIA). This product was tested by FDA through a certified laboratory to be positive for Salmonell

Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension 2400 mg/30 mL due to Microbial Contamination
Mon, 09/09/2019 - 12:14

Plastikon Healthcare, LLC isvoluntarily recalling Milk of Magnesia 2400 mg/30 mL Oral Suspension, lots 19027D and 19027E, to the patient level. Plastikon Healthcare initiated this recall because these product lots did not meet Plastikon’s in-house microbiological specification for Total Aerobic Mic

Udi’s Classic Hamburger Buns Recalled due to Potential Presence of Foreign Material
Fri, 09/06/2019 - 20:37

Conagra Brands is voluntarily recalling a limited quantity (approx. 2,200 cases) of Udi’s Classic Hamburger Buns due to the potential presence of small pieces of white plastic.

Great One Trading Inc. Issues Allergy Alert on Undeclared Egg in Fish Cakes
Wed, 09/04/2019 - 12:06

Great One Trading Inc. is recalling the above because it may contain undeclared egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume these products.

Great One Trading Inc. Issues Expanding Allergy Alert on Undeclared Egg In Fishball Products
Wed, 09/04/2019 - 11:06

Great One Trading Inc. is recalling the above because it may contain undeclared egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume these products.

Dog Goods USA LLC To Conduct A Voluntary Recall of Chef Toby Pig Ears Treats Because of Possible Salmonella Health Risk
Tue, 09/03/2019 - 17:51

Dog Goods USA LLC to conduct a voluntary recall of Chef Toby Pig Ears Treats because of possible salmonella health risk.

Dog Goods USA LLC Expands Voluntary Recall of Chef Toby Pig Ears Pet Treats Because of Possible Salmonella Health Risk on 9/3/2019
Tue, 09/03/2019 - 17:37

Dog Goods is voluntarily expanding this recall to include all 30-packs of "Berkley & Jensen" brand pig ears sold at BJ's Wholesale Club stores. Dog Goods purchased these pig ears from a single supplier in Brazil from September 2018 through August 2019.

Hiland Dairy Announces Voluntary Recall of Hiland Dairy Half-Gallon and Pint Lemonades
Fri, 08/30/2019 - 22:31

Hiland Dairy is announcing a voluntary recall of one-half gallon (64-ounce) and pint (12-ounce) lemonade that is produced at the Chandler, Oklahoma facility, over concerns the products may contain milk that could affect those individuals that have sensitivity to dairy milk allergens.

Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab
Fri, 08/30/2019 - 17:42

AmEx Pharmacy today announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable that are within expiry to the healthcare provider level. These lots are being recalled out of an abundance of caution following an F

Mountain Mel’s Essential Goods, LLC Recalls The Milk Lady’s Herbal Tea Blend, Peaceful Baby Herbal Tea Blend, and Diges-teas Herbal Tea Blend, Because of Possible Health Risk
Thu, 08/29/2019 - 20:01

Mountain Mel’s Essential Goods, LLC of Welches, OR is recalling The Milk Lady’s Tea with LOT # ML6271950, Peaceful Baby Herbal Tea with LOT # PB781950, and Diges-Teas Herbal Tea with LOT # DT7619100, because it has the potential to be contaminated with Salmonella, an organism which can cause serious

Makzemo LLC Recalls Balquis Yemeni Spice Because of Possible Health Risk
Thu, 08/29/2019 - 12:08

Makzemo LLC of Brooklyn, NY is recalling Balquis Yemeni spice, because it has the potential to be contaminated with lead.

Brutus & Barnaby LLC recalls all size bags of “Pig Ears Natural Treats for Dogs” because of a possible salmonella health risk
Wed, 08/28/2019 - 14:46

Brutus & Barnaby of Clearwater, Florida is recalling all size variations of our Pig Ears for Dogs because it has the potential to be contaminated with Salmonella. Salmonella can affect animals eating the products and there is risk to humans from handling contaminated pet products, especially if they

Nature’s One Voluntarily Issues Allergy Alert for Undeclared Milk Allergen
Wed, 08/28/2019 - 11:05

Nature’s One, Lewis Center, Ohio is recalling PediaSmart® SOY Vanilla Beverage Mix because milk is not listed under the “contains” label statement. Each lot is tested for milk allergen by independent 3rd party laboratories before release for sale.

Krasnyi Oktyabr USA Inc Issues Alert on Undeclared Sulfites in “Tainy Vostoka Assorted Dry Fruits Quince”
Fri, 08/23/2019 - 19:05

Krasnyi Oktyabr USA Inc of Brooklyn, NY is recalling its 500gram (17.65oz) packages of “TAINY VOSTOKA ASSORTED DRIED FRUITS - QUINCE” because they contain undeclared sulfites

Krasnyi Oktyabr USA Inc Issues Alert on Undeclared Sulfites in “Tainy Vostoka Assorted Dry Fruits Apple”
Fri, 08/23/2019 - 19:05

Krasnyi Oktyabr USA Inc of Brooklyn, NY is recalling its 500gram (17.65oz) packages of “TAINY VOSTOKA ASSORTED DRIED FRUITS -APPLE” because they contain undeclared sulfites.

Altaire Pharmaceuticals, Inc. Issues Voluntary Recall Of Veterinary Ophthalmic Products
Fri, 08/23/2019 - 13:08

Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Veterinary ophthalmic drug products and lots, within expiry, identified below. This recall is only for the specific lots listed. No other lots are being recalled.

Allergy Alert for Undeclared Egg in “Decorated Red Apple Cookies” Issued by Southern Pacific Whole Foods Market Stores
Thu, 08/22/2019 - 18:22

“Decorated Red Apple Cookies” are being voluntarily recalled by Southern Pacific Whole Foods Market stores because they may contain undeclared egg

What's New: Drugs RSS Feed

What's New Related to Drugs
Tue, 09/10/2019 - 17:25

Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Recently Issued Guidance Documents
Tue, 09/10/2019 - 15:50

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

CDER Manual of Policies & Procedures (MAPP)
Tue, 09/10/2019 - 14:45

(CDER)Manual of Policies & Procedures (MAPP)

MedWatch: The FDA Safety Information and Adverse Event Reporting Program
Tue, 09/10/2019 - 14:35

MedWatch home page

Meetings, Conferences, & Workshops (Drugs)
Tue, 09/10/2019 - 14:22

Drugs-Related Meetings

Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance
Tue, 09/10/2019 - 13:15

Hospira, Inc., a Pfizer company, is voluntarily recalling BACTERIOSTATIC WATER for Injection, USP, 30 mL, multi-dose vial, lot W20308, to the Hospital/Retail level. Hospira initiated this recall due to lack of confirmation of sterilization for some vials from this lot.

Drug Shortages | Additional News and Information
Tue, 09/10/2019 - 12:37

Drug Shortages: Additional News and Information

Public Notification: JaDera PLUS contains hidden drug ingredients
Tue, 09/10/2019 - 11:21

The Food and Drug Administration is advising consumers not to purchase or use JaDera PLUS, a product promoted for weight loss. This product was identified during an examination of international mail shipments.

Dermatologic and Ophthalmic Drugs Advisory Committee Roster
Tue, 09/10/2019 - 11:07

This page contains the DODAC roster, which lists the current members and the current number of vacancies for the committee.

Frequently requested or proactively posted compliance records
Tue, 09/10/2019 - 09:55

Frequently requested inspection records of foreign pharmaceutical manufacturing facilities

Field Science - Laboratory Manual
Tue, 09/10/2019 - 09:51

The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and cour

Hangzhou Badi Daily Use Chemical Company - 580819 - 08/29/2019
Tue, 09/10/2019 - 09:21

CGMP/Finished Pharmaceuticals/Adulterated/Unapproved or Misbranded


Sharp Drugs, Inc. dba Island Drug and Surgical - 588331 - 08/02/2019
Tue, 09/10/2019 - 09:21

Drug Product/Adulterated


Enprani Co., Ltd. - 580548 - 08/15/2019
Tue, 09/10/2019 - 09:21

CGMP/Finished Pharmaceuticals/Adulterated/Failure to Register

Public Notification: Anaconda Strong Formula contains hidden drug ingredient
Mon, 09/09/2019 - 17:36

The Food and Drug Administration is advising consumers not to purchase or use Anaconda Strong Formula, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

June 11-12, 2019: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee - 06/11/2019 - 06/12/2019
Mon, 09/09/2019 - 17:15

June 11-12, 2019: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee

Public Notification: Lung Leader contains hidden drug ingredient
Mon, 09/09/2019 - 17:06

The Food and Drug Administration is advising consumers not to purchase or use Lung Leader, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

Public Notification: LOBO contains hidden drug ingredient
Mon, 09/09/2019 - 17:05

The Food and Drug Administration is advising consumers not to purchase or use LOBO, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

Public Notification: La Pepa Negra contains hidden drug ingredient
Mon, 09/09/2019 - 16:42

The Food and Drug Administration is advising consumers not to purchase or use La Pepa Negra, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

[9-6-2019] The Food and Drug Administration is advising consum

Statement on improving adverse event reporting of compounded drugs to protect patients
Mon, 09/09/2019 - 16:11

The FDA is working to improve adverse event reporting of compounded drugs to protect patients

Whats New Vaccines Blood Biologics RSS Feed

Devices Guidances
Tue, 09/10/2019 - 15:52

This page lists Medical Device Guidance documents.

Recently Issued Guidance Documents
Tue, 09/10/2019 - 15:51

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

MedWatch: The FDA Safety Information and Adverse Event Reporting Program
Tue, 09/10/2019 - 14:36

MedWatch home page

What’s New for Biologics
Tue, 09/10/2019 - 14:23

Latest news from the Center for Biologics Evaluation and Research

0.9 % Sodium Chloride Injection USP
Tue, 09/10/2019 - 13:56

A pre-attached subassembly component of an apheresis kit for apheresis kit priming and/or for use as a replenishment fluid to maintain isovolemia in subjects undergoing an apheresis procedure.

Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies
Tue, 09/10/2019 - 11:23

Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies; final; C. difficile infection, Fecal microbiota, CBER, Biologics

2019 Meeting Materials, Allergenic Products Advisory Committee
Tue, 09/10/2019 - 11:10

This is the main page for the CBER 2019 Meeting Materials, Allergenic Products Advisory Committee.

New Drug Applications with Supporting Documents
Tue, 09/10/2019 - 10:36

List including applications in alphabetical order by product name for which have approval documents available, and reflects the information as of the approval date.

Field Science - Laboratory Manual
Tue, 09/10/2019 - 09:51

The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and cour

Licensed Biological Products with Supporting Documents
Tue, 09/10/2019 - 09:40

Licensed biological products with supporting documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

Innovation and Regulatory Science
Mon, 09/09/2019 - 17:25

Innovation and Regulatory Science

FDA identifies biomarker for immune response to FVIII products used to treat hemophilia A
Mon, 09/09/2019 - 17:18

FDA identifies biomarker for immune response to FVIII products used to treat hemophilia A

How do I request a Patient Listening Session?
Mon, 09/09/2019 - 14:41

Learn about how to request a Listening Session with the FDA to share your experience with a disease or condition.

Fast Track Designation Request Performance
Mon, 09/09/2019 - 12:25

The Food and Drug Administration Modernization Act of 1997 (FDAMA) includes Section 112, "Expediting study and approval of fast track drugs." This section mandates the Agency to facilitate the development and expedite review of drugs and biologics intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track adds to existing programs, such as accelerated approval, the possibility of a "rolling submission" for a marketing application. An important feature of fast track is that it emphasizes the critical nature of close early communication between the FDA and sponsor to improve the efficiency of product development.

Jobs at the Center for Biologics Evaluation and Research (CBER)
Mon, 09/09/2019 - 08:55

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

Physician, Division of Epidemiology (DE) - Title 38(F) Physician (GP-0602)
Mon, 09/09/2019 - 08:50

The Center for Biologics Evaluation and Research is recruiting to fill a Physician position to serve in the Division of Epidemiology in the Office of Biostatistics and Epidemiology.

Consumer Updates
Mon, 09/09/2019 - 08:20

Get timely, reliable, health and safety information about food, drugs, medical devices, vaccines, pet food, pet medicine and more.

Guidance and Other Information of Special Interest to MCM Stakeholders
Fri, 09/06/2019 - 15:52

Information of particular interest to sponsors/applicants of medical countermeasures to treat, prevent, diagnose, and detect chemical, biological, radiological, and nuclear threats and emerging infectious diseases

Antimicrobial Resistance Information from FDA
Fri, 09/06/2019 - 15:50

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

MCM-Related Guidance by Date
Fri, 09/06/2019 - 15:50

Guidances and other information of special interest to MCM stakeholders, sponsors and applicants, listed by date


Here are some headlines supporting the benefits of a system like ADERS ®:



See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.




Corporate Headquarters

Practical Compliance Solutions
One Orient Way - Suite F156 Rutherford, NJ 07070
Phone: 201-728-8809


40.827731 N 74.101029 W
Connect With Us


Share




© 2002 - 2019 - Copyright Practical Compliance Solutions - All rights reserved